Catalyst
Slingshot members are tracking this event:
FDA Approves Design for Global Blood's (GBT) Phase 3 Hope Trial Evaluating GBT440 in Sickle Cell Disease
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GBT |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 24, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Fda, Phase 3, Hope Trial, Gbt440, Design Approval, Sickle Cell Disease
